Bernadette A Tumanan-Mendoza1,2, Victor L Mendoza3,4, April Ann A Bermudez-Delos Santos1, Felix Eduardo R Punzalan1,5, Noemi S Pestano1, Rudy Boy Natividad1, Louie Alfred Shiu1, Renelene Macabeo1, Hilton Y Lam6. 1. Department of Internal Medicine, Section of Cardiology, Manila Doctors Hospital, Manila, Philippines. 2. Department of Clinical Epidemiology, University of the Philippines Manila, College of Medicine, Manila, Philippines. 3. Department of Internal Medicine, Section of Cardiology, De La Salle University Medical Center, Dasmariñas, Cavite, Philippines. 4. Department of Physiology, De La Salle Health Sciences Institute, Dasmariñas, Cavite, Philippines. 5. Department of Internal Medicine, Section of Cardiology, Philippine General Hospital, Manila, Philippines. 6. Institute of Health Policy Development, National Institutes of Health, University of the Philippines, Manila, Philippines.
Abstract
OBJECTIVES: Hospitalisation for congestive heart failure (CHF) was reported to be 1648 cases for every 100 000 patient claims in 2014 in the Philippines; however, there are no data regarding its economic impact. This study determined CHF hospitalisation cost and its total economic burden. It compared the healthcare-related hospitalisation cost from the societal perspective with the payer's perspective, the Philippine Health Insurance Corporation (PhilHealth). METHODS: This is a cost analysis study. Data were obtained from representative government/private hospitals and a drugstore in all regions of the country. Healthcare costs included cost of diagnostics/treatment, professional fees and other CHF-related hospital charges, while non-healthcare costs included production losses, transportation and food expenses. RESULTS: The overall mean healthcare-related cost for CHF hospitalisation (class III) in government hospitals in the Philippines in 2014 was PHP19 340-PHP28 220 (US$436-US$636). In private hospitals, it was PHP28 370-PHP41 800 (US$639-US$941). In comparison, PhilHealth's coverage/CHF case rate payment is PHP15 700 (US$354). The mean non-healthcare cost was PHP10 700-PHP14 600 (US$241-US$329). Using PhilHealth's case rate payment and the prevalence of CHF hospitalisation in 2014, the total economic burden was PHP691 522 200 (US$15 574 824). Using the study results on healthcare-related cost meant that the total economic burden for CHF hospitalisation would instead be PHP851 850 000-PHP1 841 563 000 (US$19 185 811-US$41 476 644). CONCLUSIONS: The calculated healthcare-related hospitalisation cost for CHF in the Philippines in 2014 demonstrates the disparity between the actual cost and PhilHealth's coverage. This implies a need for policymakers to review its coverage to make healthcare delivery affordable.
OBJECTIVES: Hospitalisation for congestive heart failure (CHF) was reported to be 1648 cases for every 100 000 patient claims in 2014 in the Philippines; however, there are no data regarding its economic impact. This study determined CHF hospitalisation cost and its total economic burden. It compared the healthcare-related hospitalisation cost from the societal perspective with the payer's perspective, the Philippine Health Insurance Corporation (PhilHealth). METHODS: This is a cost analysis study. Data were obtained from representative government/private hospitals and a drugstore in all regions of the country. Healthcare costs included cost of diagnostics/treatment, professional fees and other CHF-related hospital charges, while non-healthcare costs included production losses, transportation and food expenses. RESULTS: The overall mean healthcare-related cost for CHF hospitalisation (class III) in government hospitals in the Philippines in 2014 was PHP19 340-PHP28 220 (US$436-US$636). In private hospitals, it was PHP28 370-PHP41 800 (US$639-US$941). In comparison, PhilHealth's coverage/CHF case rate payment is PHP15 700 (US$354). The mean non-healthcare cost was PHP10 700-PHP14 600 (US$241-US$329). Using PhilHealth's case rate payment and the prevalence of CHF hospitalisation in 2014, the total economic burden was PHP691 522 200 (US$15 574 824). Using the study results on healthcare-related cost meant that the total economic burden for CHF hospitalisation would instead be PHP851 850 000-PHP1 841 563 000 (US$19 185 811-US$41 476 644). CONCLUSIONS: The calculated healthcare-related hospitalisation cost for CHF in the Philippines in 2014 demonstrates the disparity between the actual cost and PhilHealth's coverage. This implies a need for policymakers to review its coverage to make healthcare delivery affordable.
Entities:
Keywords:
delivery of care; heart failure; public health
Authors: Robert O Bonow; Theodore G Ganiats; Craig T Beam; Kathleen Blake; Donald E Casey; Sarah J Goodlin; Kathleen L Grady; Randal F Hundley; Mariell Jessup; Thomas E Lynn; Frederick A Masoudi; David Nilasena; Ileana L Piña; Paul D Rockswold; Lawrence B Sadwin; Joanna D Sikkema; Carrie A Sincak; John Spertus; Patrick J Torcson; Elizabeth Torres; Mark V Williams; John B Wong Journal: Circulation Date: 2012-04-23 Impact factor: 29.690
Authors: John A Spertus; Kim A Eagle; Harlan M Krumholz; Kristi R Mitchell; Sharon-Lise T Normand Journal: Circulation Date: 2005-04-05 Impact factor: 29.690
Authors: Bernadette A Tumanan-Mendoza; Victor L Mendoza; April Ann A Bermudez-Delos Santos; Felix Eduardo R Punzalan; Noemi S Pestaño; Rudy Boy Natividad; Louie Alfred Shiu; Renelene Macabeo Journal: Heart Asia Date: 2017-03-27
Authors: Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Mark H Drazner; Gregg C Fonarow; Stephen A Geraci; Tamara Horwich; James L Januzzi; Maryl R Johnson; Edward K Kasper; Wayne C Levy; Frederick A Masoudi; Patrick E McBride; John J V McMurray; Judith E Mitchell; Pamela N Peterson; Barbara Riegel; Flora Sam; Lynne W Stevenson; W H Wilson Tang; Emily J Tsai; Bruce L Wilkoff Journal: Circulation Date: 2013-06-05 Impact factor: 29.690
Authors: Bernadette A Tumanan-Mendoza; Victor L Mendoza; Felix Eduardo R Punzalan; Paul Ferdinand M Reganit; Silverose Ann A Bacolcol Journal: Value Health Reg Issues Date: 2015-05-16
Authors: Cecilia Jimeno; Rosa Allyn Sy; Pepito De La Pena; Chritopher Cipriano; Rima Tan; Araceli Panelo; Junice Yi Siu Ng Journal: BMJ Open Date: 2021-10-11 Impact factor: 3.006